AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
ImaRx Therapeutics, Inc. (NASDAQ:IMRX), Tucson, Ariz. has reported financial results for the quarter and six months ended June 30, 2007, and provided a business update. Revenue for the second quarter ended June 30, 2007 was approximately $2.2 million, compared to approximately $0.3 million for the second quarter of 2006. Revenue for the six months ended June 30, 2007 was approximately $3.4 million, compared to approximately $0.4 million for the six months ended June 30, 2006. The increase in revenues for each of the periods was primarily the result of the commencement of sales of Abbokinase which accounted for approximately $2.0 million of revenue in the second quarter.
Net loss for the second quarter of 2007 was approximately $1.5 million as compared to a net loss of approximately $4.1 million for the second …
Source: HighBeam Research, IMAXRX THERAPEUTICS HAS 2ND QTR 2007 NET LOSS OF $1.5 MIL.(revenue...